The week in health tech, explained in plain English.Get the free newsletter →
October 4, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Payers

Judge Sends Ballad Health's UnitedHealth MA Suit to Arbitration

A federal judge has dismissed Johnson City, Tennessee-based Ballad Health's lawsuit against UnitedHealth Group, ruling that the two parties must settle their Medicare Advantage payment dispute in arbitration rather than in court, according to Becker's Hospital Review.

Ballad sued UnitedHealth in October, alleging the insurer spent years denying valid claims, delaying payment, and overstating the severity of patient illnesses to boost its own Medicare Advantage reimbursements. The dismissal does not resolve those claims. It shifts them into private arbitration, a process that typically keeps disputes out of public view and away from a jury.

The case reflects growing friction between health systems and Medicare Advantage insurers over denials and slow payment. A number of hospitals have publicly clashed with, or dropped, MA plans they say make payment too difficult. For providers, the ruling is a reminder that arbitration clauses buried in payer contracts can determine where these fights get decided, limiting the leverage of a public lawsuit.

More in Payers

Payers

7 Health System Insurers to Exit Medicare Advantage in 2027

Seven health system-owned insurers are among 11 health plans exiting the individual Medicare Advantage market in 2027, with several others narrowing to special needs plans only.

Why it matters: The exits signal that even provider-owned plans are struggling with Medicare Advantage economics, forcing seniors to find new coverage.

Payers

CMS Projects Lower MA Premiums, Flat Enrollment for 2027

CMS projects lower average Medicare Advantage premiums and flat enrollment of 34 million for 2027, a figure that already trails current membership of 36.1 million.

Why it matters: Medicare Advantage now covers nearly half of all Medicare enrollees, so its premium and growth trajectory shapes revenue for insurers, providers, and the federal budget.

Payers

PBMs Become Rare Bipartisan Target in Washington and States

A bipartisan push in Congress and statehouses aims to rein in pharmacy benefit managers, including proposals to force CVS and rivals to split their PBM and pharmacy businesses.

Why it matters: PBMs sit at the center of US drug pricing, and forced divestiture would upend the business models of the largest healthcare conglomerates.